ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2014

Rapamycin combined with celecoxib enhanced antitumor effects of mono treatment on chronic myelogenous leukemia cells through downregulating mTOR pathway.

Jie Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.